Regenerative Medical Technology (RMTG) Receivables (2021 - 2026)
Regenerative Medical Technology (RMTG) recorded Receivables of $110,244 in Q2 2026, up 200.6% from $36,676 a year earlier and up 216.6% from the prior quarter.
Regenerative Medical Technology (RMTG) Receivables (2021 - 2026) Analysis & Trends
At the end of FY2025, Regenerative Medical Technology reported Receivables of $43,815, up 93.8% from FY2024.
- Annual Receivables has a four-year compound annual growth rate of 6.1% (FY2021 to FY2025).
- Across earlier years, Receivables came in at $22,605 in FY2024 (-5.6%), $23,956 in FY2023 (-51.9%), $49,766 in FY2022 (+44.2%) and $34,513 in FY2021.
- Quarterly Receivables has ranged from $16,306 in Q1 2025 to $114,006 in Q3 2025 over the past five years.
- On a year-over-year basis, Receivables has increased for five consecutive quarters, with growth averaging 81.0% over the last eight quarters.
- Peak year-over-year performance for Receivables in the last five years was growth of 267.7% in Q3 2025, against a decline of 90.8% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $34,821 (Q1 2026), $43,815 (Q4 2025) and $114,006 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Regenerative Medical Technology | 549,558.71 | -3.98 Mn | 2.58 Mn | 110,244.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 110,244.00 |
| Mar 31, 2026 | 34,821.00 |
| Dec 31, 2025 | 43,815.00 |
| Sep 30, 2025 | 114,006.00 |
| Jun 30, 2025 | 36,676.00 |
| Mar 31, 2025 | 16,306.00 |
| Dec 31, 2024 | 22,605.00 |
| Sep 30, 2024 | 31,006.00 |
| Jun 30, 2024 | 24,188.00 |
| Mar 31, 2024 | 43,506.00 |
| Dec 31, 2023 | 23,956.00 |
| Sep 30, 2023 | 35,011.00 |
| Jun 30, 2023 | 51,261.00 |
| Mar 31, 2023 | 102,761.00 |
| Dec 31, 2022 | 49,766.00 |
| Jun 30, 2022 | 23,027.00 |
| Mar 31, 2022 | 60,184.00 |
| Dec 31, 2021 | 34,513.00 |
| Sep 30, 2021 | 38,669.00 |
| Jun 30, 2021 | 250,000.00 |
Regenerative Medical Technology Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=RMTG&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "RMTG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=RMTG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();